HLB Therapeutics Co.,Ltd. (115450.KQ) — Stock Score Summary

HLB Therapeutics Co.,Ltd. (115450.KQ) has a MoatMap StockRank of 22/100 based on Quality (32/100), Value (49/100), and Momentum (28/100) factor scores. The current signal is SELL.

HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally.

Key Financial Metrics

Price$1.59
Market Cap$147M
Price/Book1.42
Return on Equity-5.4%
Return on Invested Capital-4.5%
Debt/Equity22.91
Gross Margin10.8%
Operating Margin-24.8%
Revenue Growth-13.3%
Free Cash Flow$-6K

HLB Therapeutics Co.,Ltd. operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is HLB Therapeutics Co.,Ltd.’s (115450.KQ) StockRank?
MoatMap’s StockRank for HLB Therapeutics Co.,Ltd. (115450.KQ) is 22/100, with a Sell signal. It is a composite of Quality (32), Value (49), and Momentum (28) factor ranks across MoatMap’s 19,000+ stock universe.
Does HLB Therapeutics Co.,Ltd. have an economic moat?
HLB Therapeutics Co.,Ltd. (115450.KQ) has a Quality factor score of 32/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is HLB Therapeutics Co.,Ltd. a buy, hold, or sell?
MoatMap’s current signal for HLB Therapeutics Co.,Ltd. (115450.KQ) is Sell, based on a StockRank of 22/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is HLB Therapeutics Co.,Ltd. in?
HLB Therapeutics Co.,Ltd. (115450.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks115450.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock